Novo Nordisk executive Gordon Findlay dramatically collapsed in the Oval Office during a live press conference at the White House. He had been standing behind President Donald Trump as the administration announced a new agreement focused on weight-loss medications.
According to witnesses, Findlay’s knees suddenly gave way. Administration staff and pharmaceutical representatives immediately rushed to support him and prevent him from falling. The event was part of the “Most Favored Nations Oval Office Announcement.”
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly,”
— White House Press Secretary Karoline Leavitt
The White House confirmed that on-site medics responded immediately and reported that Findlay recovered without serious injury. Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, reportedly assisted in lowering Findlay safely to the ground, helping prevent a head injury. Reporters were briefly asked to leave as cabinet members provided aid.
During a White House announcement on medical policy, Novo Nordisk executive Gordon Findlay fainted behind President Trump but was quickly treated and is now in stable condition.